In this study, flow cytometry and immunofluorescence were used to demonstrate the high expression of CD36 on CD8+ T cells, indicating exhausted immune function, with a correlation to worse clinical characteristics, worse prognosis, and inferior chemotherapy response in NSCLC patients. The gene discussed is CD36; the disease is non-small cell lung carcinoma.